Company intelligence / Profile preview

KDL Biotech

Savroli, Maharashtra, Indiakdl.org ↗

Ownership: Private
Development stage: Other

Overview

KDL Biotech was a major Indian manufacturer of bulk drugs and drug intermediates, especially semi-synthetic penicillins and the enzyme used to convert Penicillin-G to 6APA. The company changed its name from Kopran Drugs Limited in 2000 as it expanded into biotechnology-based products. It operated out of Maharashtra but has since ceased operations with its plant dismantled.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeEnzyme
Industry: Biotech

Beyond the preview

Go deeper on KDL Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KDL Biotech.

Explore the full profile